Market Overview:
The global biomarker market is expected to reach USD XX million by 2030, at a CAGR of XX% during the forecast period. The growth in this market can be attributed to the increasing demand for personalized medicine, rising prevalence of chronic diseases, and technological advancements in biomarker detection methods. The global biomarker market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into consumables and services. The consumables segment accounted for a larger share of the global biomarker market in 2017 owing to their growing demand for use in diagnostics development and drug discovery & development applications. By application, the global biomarker market is classified into diagnostics development, drug discovery & development, disease-risk assessment/screening/prediction), and others (toxicity testing). The diagnostics development segment held a major share of this market in 2017 due to its increasing use for early diagnosis of various diseases.
Product Definition:
A biomarker is a substance or characteristic that can be measured to indicate the presence or progress of a disease or condition. Biomarkers may be used to diagnose a disease, monitor its progress, and/or predict its outcome.
Consumables:
Consumables are the tools and materials that are used in various procedures during a study. It includes reagents, assay kits, controls & certifications, and other consumables such as instruments. The growth factor of consumables is due to its usage in repeated studies; it helps to determine the prevalence of diseases more accurately.
Service:
A biomarker is a substance that is released by an injured or diseased cell and serves as an indicator of the disease process. Biomarkers are most commonly associated with oncology, autoimmune diseases, and neurodegenerative diseases.
Application Insights:
The disease-risk application segment dominated the global market in 2017. The growing prevalence of chronic diseases, such as cancer, diabetes and cardiovascular diseases is expected to drive the demand for biomarkers over the forecast period. Biomarker discovery has helped reduce treatment time for several chronic conditions by enabling early diagnosis through point-of-care testing.
On the other hand, diagnostics development segment is projected to witness lucrative growth during the forecast period owing to increasing investments in R&D pertaining to novel diagnostic tests and rising adoption of these tests across various applications including drug discovery & development and clinical trials. In addition, an increase in investment by companies such as Amgen Inc., Quest Diagnostics Inc., Laboratory Corporation of America Holdings LLC (LabCorp) and others are expected to boost industry growth over the coming years.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for advanced diagnostic techniques are some of the major factors contributing to its growth. Moreover, increasing prevalence of chronic diseases such as cancer, diabetes and cardiovascular disorders is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by governments in developing countries coupled with growing awareness regarding early diagnosis & treatment for various diseases. Furthermore, increasing disposable income levels and demand for better healthcare services are also likely to contribute toward regional growth over next eight years.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for biomarkers that can help in early diagnosis and treatment of these diseases.
- Advances in technology: The development of new technologies such as next-generation sequencing (NGS) has led to a significant increase in the use of biomarkers for diagnostics and research purposes. This has resulted in a growing demand for biomarker products and services worldwide.
- Growing awareness about personalized medicine: There is growing awareness among people about the benefits of personalized medicine, which uses biomarkers to identify specific treatments for individual patients based on their genetic makeup or other characteristics. As a result, there is increasing demand for diagnostic tests that use biomarkers to personalize treatment plans accordingly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biomarker Market Research Report
By Type
Consumables, Service
By Application
Diagnostics Development, Drug Discovery and Development, Disease-Risk
By Companies
QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Enzo Biochem, Inc. (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Biomarker Market Report Segments:
The global Biomarker market is segmented on the basis of:
Types
Consumables, Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostics Development, Drug Discovery and Development, Disease-Risk
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- QIAGEN N.V. (Netherlands)
- PerkinElmer, Inc. (U.S.)
- Merck Millipore (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Enzo Biochem, Inc. (U.S.)
Highlights of The Biomarker Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Consumables
- Service
- By Application:
- Diagnostics Development
- Drug Discovery and Development
- Disease-Risk
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biomarker Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A biomarker is a biological indicator of disease or health.
Some of the major players in the biomarker market are QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Enzo Biochem, Inc. (U.S.).
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biomarker Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biomarker Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biomarker Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biomarker Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biomarker Market Size & Forecast, 2020-2028
4.5.1 Biomarker Market Size and Y-o-Y Growth
4.5.2 Biomarker Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Consumables
5.2.2 Service
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostics Development
6.2.2 Drug Discovery and Development
6.2.3 Disease-Risk
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biomarker Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biomarker Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Consumables
9.6.2 Service
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostics Development
9.10.2 Drug Discovery and Development
9.10.3 Disease-Risk
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Consumables
10.6.2 Service
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostics Development
10.10.2 Drug Discovery and Development
10.10.3 Disease-Risk
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Consumables
11.6.2 Service
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostics Development
11.10.2 Drug Discovery and Development
11.10.3 Disease-Risk
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Consumables
12.6.2 Service
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostics Development
12.10.2 Drug Discovery and Development
12.10.3 Disease-Risk
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Consumables
13.6.2 Service
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostics Development
13.10.2 Drug Discovery and Development
13.10.3 Disease-Risk
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biomarker Market: Competitive Dashboard
14.2 Global Biomarker Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 QIAGEN N.V. (Netherlands)
14.3.2 PerkinElmer, Inc. (U.S.)
14.3.3 Merck Millipore (U.S.)
14.3.4 Bio-Rad Laboratories, Inc. (U.S.)
14.3.5 Enzo Biochem, Inc. (U.S.)
